Related Experiment Video
Updated: Aug 11, 2026

Blood Collection from the American Horseshoe Crab, Limulus Polyphemus
Published on: October 13, 2008
Collection of white blood cell-reduced plasma by apheresis
Hans Vrielink1, Pieter F van der Meer
1Sanquin Blood Bank Northwest Region, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands. h.vrielink@sanquin.nl
Background:
WBC reduction of cellular blood components has been introduced in many countries. Owing to concerns of residual WBCs in plasma, a new method to collect WBC-reduced plasma by apheresis was studied.
Study Design And Methods:
An apheresis machine (PCS2, Haemonetics) was used, in combination with the "high-separation" core (HSC) bowl, a redesigned version of the blow-molded (BM) bowl. With the BM bowl collections as control group, various software settings were investigated applying the HSC bowl. The optimized program was validated for routine application. Results are expressed as means +/- SD.
Results:
Plasma collected in the control group with the BM bowl (n = 25) had a volume of 622 +/- 7 mL and contained 5.3 +/- 4.6 x 10(6) WBCs per L, 11 +/- 5 x 10(9) PLTs per L, and 0.063 +/- 0.051 x 10(9) RBCs per L. The collection efficiency was 17.8 +/- 2.8 mL per minute, and the total procedure time was 36.1 +/- 6.3 minutes. The HSC bowl produced plasma that had a volume of 623 +/- 9 mL and contained 0.01 +/- 0.02 x 10(6) WBCs per L, 2 +/- 2 x 10(9) PLTs per L, and 0.00040 +/- 0.0016 x 10(9) RBCs per L (n = 134, all p < 0.001). The collection efficiency was 15.8 +/- 2.2 mL per minute, and the collection time was 40.3 +/- 6.3 minutes (both p < 0.001).
Conclusion:
The HSC bowl with the new software reliably produces WBC-reduced apheresis plasma, with a slight elongation of the procedure time.
More Related Videos
11:31Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
Published on: November 30, 2015
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021